ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,472, issued on April 29, was assigned to GlaxoSmithKline Intellectual Property (No.2) Ltd. (Great Britain).
"Biopharmaceutical compositions and methods for pediatric patients" was invented by Jahanara Azmi (Middlesex, Great Britain) and Jonathan Steinfeld (Collegeville, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases in pediatric subjects, and related methods."
The patent was filed on June 8, 2022, under Application No. 17/835,321.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parse...